51
|
Goddu S, Sun B, Grantham K, Zhao T, Zhang T, Bradley J, Mutic S. TH-CD-201-10: Highly Efficient Synchronized High-Speed Scintillation Camera System for Measuring Proton Range, SOBP and Dose Distributions in a 2D-Plane. Med Phys 2016. [DOI: 10.1118/1.4958132] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
52
|
Henke L, Przybysz D, Kashani R, Green O, Robinson C, Bradley J. EP-1225: MRI-defined GTV change during SBRT for unresectable or oligometastatic disease of the central thorax. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)32475-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
53
|
Bezjak A, Paulus R, Gaspar L, Timmerman R, Straube W, Ryan W, Garces Y, Pu A, Singh A, Videtic G, McGarry R, Iyengar P, Pantarotto J, Urbanic J, Sun A, Daly M, Grills I, Normolle D, Bradley J, Choy H. OC-0136: Primary Study Endpoint Analysis of NRG Oncology/RTOG 0813 Trial of SBRT for centrally located NSCLC. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)31385-8] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
54
|
Roach M, Rehman S, DeWees T, Bradley J, Robinson C. OC-0137: Tumour size but not location determines survival and control of lung stereotactic body radiotherapy. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)31386-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
55
|
Denmark DJ, Bradley J, Mukherjee D, Alonso J, Shakespeare S, Bernal N, Phan MH, Srikanth H, Witanachchi S, Mukherjee P. Remote triggering of thermoresponsive PNIPAM by iron oxide nanoparticles. RSC Adv 2016. [DOI: 10.1039/c5ra21617f] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
Thermoresponsive PNIPAN can be remotely triggered by embedded iron oxide nanoparticles under an AC field, and the transition temperature can be tuned by changing the ionic concentration.
Collapse
Affiliation(s)
- D. J. Denmark
- Department of Physics
- University of South Florida
- Tampa
- USA
| | - J. Bradley
- Department of Physics
- University of South Florida
- Tampa
- USA
- Department of Bioengineering
| | - D. Mukherjee
- Department of Physics
- University of South Florida
- Tampa
- USA
| | - J. Alonso
- Department of Physics
- University of South Florida
- Tampa
- USA
- BCMaterials
| | - S. Shakespeare
- Department of Physics
- University of South Florida
- Tampa
- USA
| | - N. Bernal
- Department of Physics
- University of South Florida
- Tampa
- USA
| | - M. H. Phan
- Department of Physics
- University of South Florida
- Tampa
- USA
| | - H. Srikanth
- Department of Physics
- University of South Florida
- Tampa
- USA
| | - S. Witanachchi
- Department of Physics
- University of South Florida
- Tampa
- USA
| | - P. Mukherjee
- Department of Physics
- University of South Florida
- Tampa
- USA
| |
Collapse
|
56
|
Stewart K, Vijayaraman A, Alley M, Bradley J, Dresner S. A retrospective audit of patient selection for bariatric surgery. Int J Surg 2015. [DOI: 10.1016/j.ijsu.2015.07.566] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
57
|
Stewart K, Vijayaraman A, Alley M, Bradley J, Dresner S. Bariatric surgery in patients with type 2 diabetes. Int J Surg 2015. [DOI: 10.1016/j.ijsu.2015.07.565] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
58
|
Bradley J, O'Neill B, Kent L, Hulzebos EH, Arets B, Hebestreit H, Alison J, Arets B, Boas S, Bradley J, Button B, Bye P, Cerny F, Cooper D, Downs A, Dwyer T, Forster E, Gallagher C, Gruber W, Hebestreit A, Hebestreit H, Huber M, Hulzebos E, Johnstone Z, Lands L, Lannefors L, Lessine F, Lindblad A, Lowman J, Mandrusiak A, Martensson M, McIlwaine M, Möller A, Molloy M, Montgomery G, Morrison L, Murray J, Nippins M, Orenstein D, Prasaad A, Renner S, Salhberg M, Schneiderman J, Swisher A, Urquhart D, Zeitoun M. Physical activity assessment in cystic fibrosis: A position statement. J Cyst Fibros 2015. [DOI: 10.1016/j.jcf.2015.05.011] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
59
|
Guy R, Jamil MS, Fairley C, Smith K, Grulich A, Bradley J, Kaldor J, Chen M, McNulty A, Holt M, Ryan D, Batrouney C, Russell D, Bavinton B, Keen P, Conway DP, Wand H, Prestage G. P17.07 Sexual risk behaviour predicts more frequent use of hiv self-testing: early findings from the forth trial. Br J Vener Dis 2015. [DOI: 10.1136/sextrans-2015-052270.585] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
60
|
Jamil MS, Bavinton B, Guy R, Fairley C, Grulich A, Holt M, Smith K, Chen M, McNulty A, Conway DP, Keen P, Bradley J, Russell D, Kaldor J, Prestage G. P17.10 Hiv testing self-efficacy is associated with higher hiv testing frequency and perceived likelihood to self-test among gay and bisexual men. Br J Vener Dis 2015. [DOI: 10.1136/sextrans-2015-052270.588] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
61
|
Conaghan P, Østergaard M, Bowes M, Wu C, Fuerst T, van der Heijde D, Hrycaj P, Xie Z, Zhang R, Wyman B, Bradley J, Soma K, Wilkinson B. SAT0222 Effects of Tofacitinib on MRI Endpoints in Methotrexate-Naive Early Rheumatoid Arthritis: A Phase 2 MRI Study with Semi-Quantitative and Quantitative Endpoints. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.3505] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
62
|
Yu J, Gong Y, Bar-Ad V, Giaddui T, Hu C, Gore E, Wheatley M, Witt J, Robinson C, Kong F, Bradley J, Galvin J, Xiao Y. SU-E-J-134: Optimizing Technical Parameters for Using Atlas Based Automatic Segmentation for Evaluation of Contour Accuracy Experience with Cardiac Structures From NRG Oncology/RTOG 0617. Med Phys 2015. [DOI: 10.1118/1.4924220] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
63
|
Fontanella A, Jeong J, Sonke J, Bradley J, Chen C, Deasy J. TH-AB-304-03: Tumor Control Probability Applied to Lung Cancer: A Statistical Test of the Independence of Voxel Response. Med Phys 2015. [DOI: 10.1118/1.4926118] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
64
|
Klein E, Zhao T, Sun B, Goddu S, Santanam L, Bradley J. SU-E-T-722: Technical and Clinical Experience with the 1st Single Room Proton Therapy System. Med Phys 2015. [DOI: 10.1118/1.4925086] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
65
|
van der Heijde D, Connell C, Bradley J, Gruben D, Strengholt S, Landewé R. SAT0220 Radiographic Progression in Modern RA Trials is Still a Robust Outcome: Results of Comprehensive Sensitivity Analysis in Two Phase 3 Trials with Tofacitinib. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.1962] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
66
|
Chundury A, Rehman S, Roach M, Mullen D, DeWeese T, Bradley J, Robinson C. PD-0428: Radiation pneumonitis with stereotactic body radiotherapy: effects of angiotensin converting enzyme inhibitors. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)40424-4] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
67
|
Rehman S, Roach M, Mullen D, DeWees T, Bradley J, Robinson C. PO-0673: Stereotactic body radiotherapy for histopathologically confirmed vs. presumed early stage NSCLC. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)40665-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
68
|
Klein E, Zhou T, Bradley J. OC-0250: Technical and clinical experience with the 1st single room proton therapy system. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)40248-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
69
|
Boyle DL, Soma K, Hodge J, Kavanaugh A, Mandel D, Mease P, Shurmur R, Singhal AK, Wei N, Rosengren S, Kaplan I, Krishnaswami S, Luo Z, Bradley J, Firestein GS. The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis. Ann Rheum Dis 2014; 74:1311-6. [PMID: 25398374 PMCID: PMC4431345 DOI: 10.1136/annrheumdis-2014-206028] [Citation(s) in RCA: 183] [Impact Index Per Article: 18.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/02/2014] [Accepted: 10/24/2014] [Indexed: 12/29/2022]
Abstract
Objective Tofacitinib is an oral Janus kinase (JAK) inhibitor for the treatment of rheumatoid arthritis (RA). The pathways affected by tofacitinib and the effects on gene expression in situ are unknown. Therefore, tofacitinib effects on synovial pathobiology were investigated. Methods A randomised, double-blind, phase II serial synovial biopsy study (A3921073; NCT00976599) in patients with RA with an inadequate methotrexate response. Patients on background methotrexate received tofacitinib 10 mg twice daily or placebo for 28 days. Synovial biopsies were performed on Days -7 and 28 and analysed by immunoassay or quantitative PCR. Clinical response was determined by disease activity score and European League Against Rheumatism (EULAR) response on Day 28 in A3921073, and at Month 3 in a long-term extension study (A3921024; NCT00413699). Results Tofacitinib exposure led to EULAR moderate to good responses (11/14 patients), while placebo was ineffective (1/14 patients) on Day 28. Tofacitinib treatment significantly reduced synovial mRNA expression of matrix metalloproteinase (MMP)-1 and MMP-3 (p<0.05) and chemokines CCL2, CXCL10 and CXCL13 (p<0.05). No overall changes were observed in synovial inflammation score or the presence of T cells, B cells or macrophages. Changes in synovial phosphorylation of signal transducer and activator of transcription 1 (STAT1) and STAT3 strongly correlated with 4-month clinical responses (p<0.002). Tofacitinib significantly decreased plasma CXCL10 (p<0.005) at Day 28 compared with placebo. Conclusions Tofacitinib reduces metalloproteinase and interferon-regulated gene expression in rheumatoid synovium, and clinical improvement correlates with reductions in STAT1 and STAT3 phosphorylation. JAK1-mediated interferon and interleukin-6 signalling likely play a key role in the synovial response. Trial registration number NCT00976599.
Collapse
Affiliation(s)
- D L Boyle
- University of California, San Diego School of Medicine, San Diego, California, USA
| | - K Soma
- Pfizer Inc, Groton, Connecticut, USA
| | - J Hodge
- Pfizer Inc, New York, New York, USA
| | - A Kavanaugh
- University of California, San Diego School of Medicine, San Diego, California, USA
| | - D Mandel
- Office of David R Mandel MD, Inc., Mayfield Village, Ohio, USA
| | - P Mease
- Swedish Medical Center and University of Washington, Seattle, Washington, USA
| | - R Shurmur
- Bronson Internal Medicine and Rheumatology, Battle Creek, Michigan, USA
| | - A K Singhal
- Southwest Rheumatology Research LLC, Dallas, Texas, USA
| | - N Wei
- Arthritis Treatment Center, Frederick, Maryland, USA
| | - S Rosengren
- University of California, San Diego School of Medicine, San Diego, California, USA
| | - I Kaplan
- Pfizer Inc, Groton, Connecticut, USA
| | | | - Z Luo
- Pfizer Inc, Shanghai, China
| | - J Bradley
- Pfizer Inc, Groton, Connecticut, USA
| | - G S Firestein
- University of California, San Diego School of Medicine, San Diego, California, USA
| |
Collapse
|
70
|
O'Steen L, Bradley J, Rotondo R, Vern-Gross T, Morris C, Aldana P, Sandler E, Indelicato D. RT-25 * NAUSEA AND EMESIS IN MEDULLOBLASTOMA PATIENTS TREATED WITH PROTON RADIOTHERAPY. Neuro Oncol 2014. [DOI: 10.1093/neuonc/nou270.22] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
71
|
Troncone M, Cargnelli S, Pond G, Tsiani E, Wright J, Steinberg G, Skinner H, Bo L, Bradley J. 205 Metformin to modulate AMP-kinase and enhance chemotherapy and radiotherapy in non-small cell lung cancer. Eur J Cancer 2014. [DOI: 10.1016/s0959-8049(14)70331-4] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
72
|
Timmerman R, Hu C, Michalski J, Straube W, Galvin J, Johnstone D, Bradley J, Barriger R, Bezjak A, Videtic G, Nedzi L, Werner-Wasik M, Chen Y, Komaki R, Choy H. Long-term Results of RTOG 0236: A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients with Medically Inoperable Stage I Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys 2014. [DOI: 10.1016/j.ijrobp.2014.05.135] [Citation(s) in RCA: 115] [Impact Index Per Article: 11.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
|
73
|
Klein E, Tianyu Z, Goddu S, Santanam L, Grantham K, Bradley J. Technical and Clinical Experience With the First Single Room Proton Therapy System. Int J Radiat Oncol Biol Phys 2014. [DOI: 10.1016/j.ijrobp.2014.05.719] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
74
|
Alten R, Strand V, Fleischmann R, Koncz T, Zwillich S, Bradley J, Gruben D, Wilkinson B, Krishnaswami S, Wallenstein G. OP0152 Effects of Tofacitinib Monotherapy versus Methotrexate on Patient-Reported Outcomes in the 2-Year Phase 3 Oral Start TRIAL in Methotrexate-NaÏVe Patients with Rheumatoid Arthritis. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.3168] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
75
|
Fontanella A, Robinson C, Zuniga A, Apte A, Thorstad W, Bradley J, Deasy J. SU-E-T-312: Test of the Generalized Tumor Dose (gTD) Model with An Independent Lung Tumor Dataset. Med Phys 2014. [DOI: 10.1118/1.4888644] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
76
|
Mitchell KM, Foss AM, Prudden HJ, Mukandavire Z, Pickles M, Williams JR, Johnson HC, Ramesh BM, Washington R, Isac S, Rajaram S, Phillips AE, Bradley J, Alary M, Moses S, Lowndes CM, Watts CH, Boily MC, Vickerman P. Who mixes with whom among men who have sex with men? Implications for modelling the HIV epidemic in southern India. J Theor Biol 2014; 355:140-50. [PMID: 24727187 PMCID: PMC4064301 DOI: 10.1016/j.jtbi.2014.04.005] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2013] [Revised: 04/01/2014] [Accepted: 04/02/2014] [Indexed: 11/19/2022]
Abstract
In India, the identity of men who have sex with men (MSM) is closely related to the role taken in anal sex (insertive, receptive or both), but little is known about sexual mixing between identity groups. Both role segregation (taking only the insertive or receptive role) and the extent of assortative (within-group) mixing are known to affect HIV epidemic size in other settings and populations. This study explores how different possible mixing scenarios, consistent with behavioural data collected in Bangalore, south India, affect both the HIV epidemic, and the impact of a targeted intervention. Deterministic models describing HIV transmission between three MSM identity groups (mostly insertive Panthis/Bisexuals, mostly receptive Kothis/Hijras and versatile Double Deckers), were parameterised with behavioural data from Bangalore. We extended previous models of MSM role segregation to allow each of the identity groups to have both insertive and receptive acts, in differing ratios, in line with field data. The models were used to explore four different mixing scenarios ranging from assortative (maximising within-group mixing) to disassortative (minimising within-group mixing). A simple model was used to obtain insights into the relationship between the degree of within-group mixing, R0 and equilibrium HIV prevalence under different mixing scenarios. A more complex, extended version of the model was used to compare the predicted HIV prevalence trends and impact of an HIV intervention when fitted to data from Bangalore. With the simple model, mixing scenarios with increased amounts of assortative (within-group) mixing tended to give rise to a higher R0 and increased the likelihood that an epidemic would occur. When the complex model was fit to HIV prevalence data, large differences in the level of assortative mixing were seen between the fits identified using different mixing scenarios, but little difference was projected in future HIV prevalence trends. An oral pre-exposure prophylaxis (PrEP) intervention was modelled, targeted at the different identity groups. For intervention strategies targeting the receptive or receptive and versatile MSM together, the overall impact was very similar for different mixing patterns. However, for PrEP scenarios targeting insertive or versatile MSM alone, the overall impact varied considerably for different mixing scenarios; more impact was achieved with greater levels of disassortative mixing. Different mixing scenarios are explored for 3 groups of role-segregated MSM. Models show that the mixing scenario affects both R0 and endemic HIV prevalence. When models are fit to data, predicted HIV trends are unaffected by mixing. Impact of targeted (but not non-targeted) interventions can be affected by mixing.
Collapse
Affiliation(s)
- K M Mitchell
- London School of Hygiene and Tropical Medicine, London, UK.
| | - A M Foss
- London School of Hygiene and Tropical Medicine, London, UK.
| | - H J Prudden
- London School of Hygiene and Tropical Medicine, London, UK.
| | - Z Mukandavire
- London School of Hygiene and Tropical Medicine, London, UK.
| | - M Pickles
- London School of Hygiene and Tropical Medicine, London, UK; Imperial College London, London, UK.
| | | | - H C Johnson
- London School of Hygiene and Tropical Medicine, London, UK.
| | - B M Ramesh
- Karnataka Health Promotion Trust, Bangalore, India; University of Manitoba, Winnipeg, MB, Canada.
| | - R Washington
- Karnataka Health Promotion Trust, Bangalore, India; St. John's Research Institute, Bangalore, India.
| | - S Isac
- Karnataka Health Promotion Trust, Bangalore, India.
| | - S Rajaram
- CHARME-India Project, Bangalore, India.
| | | | - J Bradley
- CHARME-India Project, Bangalore, India; Centre de recherche du CHU de Québec, Québec, QC, Canada.
| | - M Alary
- Centre de recherche du CHU de Québec, Québec, QC, Canada; Département de medicine sociale et preventive, Université laval, Québec, QC, Canada; Institut national de santé publique du Québec, Québec, QC, Canada.
| | - S Moses
- University of Manitoba, Winnipeg, MB, Canada.
| | - C M Lowndes
- Centre de recherche du CHU de Québec, Québec, QC, Canada; Public Health England, London, UK.
| | - C H Watts
- London School of Hygiene and Tropical Medicine, London, UK.
| | - M-C Boily
- Imperial College London, London, UK.
| | - P Vickerman
- University of Bristol, Bristol, UK; London School of Hygiene and Tropical Medicine, London, UK.
| |
Collapse
|
77
|
van Vollenhoven R, Riese R, Krishnaswami S, Kawabata T, Fosser C, Rottinghaus S, Lamba M, Zwillich SH, Bradley J. THU0252 Relationship between Lymphocyte Count and Risk of Infection in Rheumatoid Arthritis Patients Treated with Tofacitinib. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2013-eular.780] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
78
|
van Vollenhoven R, Wallenstein G, Lee E, Fleischmann R, Zwillich S, Gruben D, Koncz T, Bradley J, Wilkinson B, Strand V. THU0151 Effects of tofacitinib (CP-690,550), an oral janus kinase inhibitor, or adalimumab on patient reported outcomes in a phase 3 study of active rheumatoid arthritis:. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2012-eular.2116] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
79
|
Kremer J, Zerbini C, Lee E, Gruben D, Krishnaswami S, Zwillich S, Koncz T, Bradley J, Mebus C. THU0143 Tofacitinib (CP-690,550), an oral janus kinase inhibitor: Analyses of efficacy endpoints by subgroups in a pooled phase 2 and 3 rheumatoid arthritis study population. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2012-eular.2108] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
80
|
Boyle DL, Wei N, Singhal AK, Rosengren S, Kaplan I, Soma K, Hodge J, Luo Z, Krishnaswami S, Gruben D, Zwillich SH, Bradley J, Firestein GS. OP0253 The JAK Inhibitor Tofacitinib Suppresses Synovial JAK1-STAT1 Signalling in Rheumatoid Arthritis. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2013-eular.458] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
81
|
Lee E, Curtis J, Riese R, Connell C, Chew R, Boy M, Maller E, Su C, Wang L, Bradley J. THU0140 Tofacitinib (CP-690,550), an oral janus kinase inhibitor: Analysis of gastrointestinal adverse events across the rheumatoid arthritis clinical programme. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2012-eular.2105] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
82
|
Ainslie B, Alexander N, Johnston N, Bradley J, Pomeroy AC, Jackson PL, Otter KA. Predicting spatial patterns of eagle migration using a mesoscale atmospheric model: a case study associated with a mountain-ridge wind development. Int J Biometeorol 2014; 58:17-30. [PMID: 23325041 DOI: 10.1007/s00484-012-0620-0] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/04/2012] [Revised: 12/14/2012] [Accepted: 12/16/2012] [Indexed: 06/01/2023]
Abstract
High resolution numerical atmospheric modeling around a mountain ridge in Northeastern British Columbia (BC), Canada was performed in order to examine the influence of meteorology and topography on Golden Eagle migration pathways at the meso-scale (tens of km). During three eagle fall migration periods (2007-2009), local meteorological conditions on the day of peak bird counts were modeled using the Regional Atmospheric Modeling System (RAMS) mesoscale model. Hourly local surface wind speed, wind direction, temperature, pressure and relative humidity were also monitored during these migration periods. Eagle migration flight paths were observed from the ground and converted to three-dimensional tracks using ArcGIS. The observed eagle migration flight paths were compared with the modeled vertical velocity wind fields. Flight tracks across the study area were also simulated using the modeled vertical velocity field in a migration model based on a fluid-flow analogy. It was found that both the large-scale weather conditions and the horizontal wind fields across the study area were broadly similar on each of the modeled migration days. Nonetheless, the location and density of flight tracks across the domain varied between days, with the 2007 event producing more tracks to the southwest of the observation location than the other 2 days. The modeled wind fields suggest that it is not possible for the eagles to traverse the study area without leaving updraft regions, but birds do converge on the locations of updrafts as they move through the area. Statistical associations between observed eagles positions and the vertical velocity field suggest that to the northwest (and to a lesser extent the southwest) of the main study ridge (Johnson col), eagles can always find updrafts but that they must pass through downdraft regions in the NE and SE as they make their way across the study area. Finally, the simulated flight tracks based on the fluid-flow model and the vertical velocity fields are in general agreement with the observed flight track patterns. Our results suggest that use of high resolution meteorological fields to locate the occurrence of updrafts in proposed ridge-line wind installations could aid in predicting, and mitigating for, convergence points in raptor migrations.
Collapse
Affiliation(s)
- B Ainslie
- Environment Canada, 401 Burrard Street, Vancouver, BC, Canada, V6C 3S5,
| | | | | | | | | | | | | |
Collapse
|
83
|
Rowan S, Bradley J, Bradbury I, Lawson J, Lynch T, O'Neill K, Ennis M, Elborn JS. P106 Lung Clearance Index is a Repeatable Test of Lung Function and Superior Predictor of CT Scan Abnormalities in Bronchiectasis. Thorax 2013. [DOI: 10.1136/thoraxjnl-2013-204457.256] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
84
|
Anwar M, Lupo J, Molinaro A, Clarke J, Butowski N, Prados M, Chang S, HaasKogan D, Nelson S, Ashman J, Drazkowski J, Zimmerman R, Lidner T, Giannini C, Porter A, Patel N, Atean I, Shin N, Toltz A, Laude C, Freeman C, Seuntjens J, Roberge D, Back M, Kastelan M, Guo L, Wheeler H, Beauchesne P, Faure G, Noel G, Schmitt T, Martin L, Jadaud E, Carnin C, Bowers J, Bennion N, Lomas H, Spencer K, Richardson M, McAllister W, Sheehan J, Schlesinger D, Kersh R, Brower J, Gans S, Hartsell W, Goldman S, Chang JHC, Mohammed N, Siddiqui M, Gondi V, Christensen E, Klawikowski S, Garg A, McAleer M, Rhines L, Yang J, Brown P, Chang E, Settle S, Ghia A, Edson M, Fuller GN, Allen P, Li J, Garsa A, Badiyan S, Simpson J, Dowling J, Rich K, Chicoine M, Leuthardt E, Kim A, Robinson C, Gill B, Peskorski D, Lalonde R, Huq MS, Flickinger J, Graff A, Clerkin P, Smith H, Isaak R, Dinh J, Grosshans D, Allen P, de Groot J, McGovern S, McAleer M, Gilbert M, Brown P, Mahajan A, Gupta T, Mohanty S, Kannan S, Jalali R, Hardie J, Laack N, Kizilbash S, Buckner J, Giannini C, Uhm J, Parney I, Jenkins R, Decker P, Voss J, Hiramatsu R, Kawabata S, Furuse M, Niyatake SI, Kuroiwa T, Suzuki M, Ono K, Hobbs C, Vallow L, Peterson J, Jaeckle K, Heckman M, Bhupendra R, Horowitz D, Wuu CS, Feng W, Drassinower D, Lasala A, Lassman A, Wang T, Indelicato D, Rotondo R, Bradley J, Sandler E, Aldana P, Mendenhall N, Marcus R, Kabarriti R, Mourad WF, Mejia DM, Glanzman J, Patel S, Young R, Bernstein M, Hong L, Fox J, LaSala P, Kalnicki S, Garg M, Khatua S, Hou P, Wolff J, Hamilton J, Zaky W, Mahajan A, Ketonen L, Kim SH, Lee SR, Ji, Oh Y, Krishna U, Shah N, Pathak R, Gupta T, Lila A, Menon P, Goel A, Jalali R, Lall R, Lall R, Smith T, Schumacher A, McCaslin A, Kalapurakal J, Chandler J, Magnuson W, Robins HI, Mohindra P, Howard S, Mahajan A, Manfredi D, Rogers CL, Palmer M, Hillebrandt E, Bilton S, Robinson G, Velasco K, Mehta M, McGregor J, Grecula J, Ammirati M, Pelloski C, Lu L, Gupta N, Bell S, Moller S, Law I, Rosenschold PMA, Costa J, Poulsen HS, Engelholm SA, Morrison A, Cuglievan B, Khatib Z, Mourad WF, Kabarriti R, Young R, Santiago T, Blakaj DM, Welch M, Graber J, Patel S, Hong LX, Patel A, Tandon A, Bernstein MB, Shourbaji RA, Glanzman J, Kinon MD, Fox JL, Lasala P, Kalnicki S, Garg MK, Nicholas S, Salvatori R, Lim M, Redmond K, Quinones A, Gallia G, Rigamonti D, Kleinberg L, Patel S, Mourad W, Young R, Kabarriti R, Santiago T, Glanzman J, Bernstein M, Patel A, Yaparpalvi R, Hong L, Fox J, LaSala P, Kalnicki S, Garg M, Redmond K, Mian O, Degaonkar M, Sair H, Terezakis S, Kleinberg L, McNutt T, Wharam M, Mahone M, Horska A, Rezvi U, Melian E, Surucu M, Mescioglu I, Prabhu V, Clark J, Anderson D, Robbins J, Yechieli R, Ryu S, Ruge MI, Suchorska B, Hamisch C, Mahnkopf K, Lehrke R, Treuer H, Sturm V, Voges J, Sahgal A, Al-Omair A, Masucci L, Masson-Cote L, Atenafu E, Letourneau D, Yu E, Rampersaud R, Lewis S, Yee A, Thibault I, Fehlings M, Shi W, Palmer J, Li J, Kenyon L, Glass J, Kim L, Werner-wasik M, Andrews D, Susheela S, Revannasiddaiah S, Muzumder S, Mallarajapatna G, Basavalingaiah A, Gupta M, Kallur K, Hassan M, Bilimagga R, Tamura K, Aoyagi M, Ando N, Ogishima T, Yamamoto M, Ohno K, Maehara T, Xu Z, Vance ML, Schlesinger D, Sheehan J, Young R, Blakaj D, Kinon MD, Mourad W, LaSala PA, Hong L, Kalnicki S, Garg M, Young R, Mourad W, Patel S, Fox J, LaSala PA, Hong L, Graber JJ, Santiago T, Kalnicki S, Garg M, Zimmerman AL, Vogelbaum MA, Barnett GH, Murphy ES, Suh JH, Angelov L, Reddy CA, Chao ST. RADIATION THERAPY. Neuro Oncol 2013; 15:iii178-iii188. [PMCID: PMC3823902 DOI: 10.1093/neuonc/not187] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/23/2023] Open
|
85
|
Klein E, Grantham K, Bottani B, Zhu T, Bradley J. Proton Therapy Delivery Uncertainties for Single Versus Multiple Daily Fields. Int J Radiat Oncol Biol Phys 2013. [DOI: 10.1016/j.ijrobp.2013.06.1968] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
86
|
Lee S, Bradley J, Ybarra N, Jeyaseelan K, Seuntjens J, El Naqa I. TU-G-108-05: Assessment of Different Machine Learning Techniques for Multivariate Radiation Pneumonitis Modeling. Med Phys 2013. [DOI: 10.1118/1.4815454] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
87
|
Keystone E, Fleischmann R, van Vollenhoven R, Kremer J, Gruben D, Bradley J, Riese R, Mebus C, Wallenstein G, Zwillich SH, Benda B, Krishnaswami S. THU0228 Tofacitinib, an Oral Janus Kinase Inhibitor: Post-HOC Analyses of Efficacy and Safety of Monotherapy Versus Combination Therapy in a Phase 3 Rheumatoid Arthritis Population. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.756] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
88
|
Huang E, Folkert M, Bradley J, Apte A, Deasy J. TU-G-108-02: Left Atrium Dose-Volume Parameters Predict for Clinically Significant Radiation Pneumonitis. Med Phys 2013. [DOI: 10.1118/1.4815451] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
89
|
Fleischmann R, Gruben D, Krishnaswami S, Zwillich S, Benda B, Mebus C, Bradley J. THU0152 How should the primary endpoint be analysed in rheumatoid arthritis trials which mandate rescue prior to the clinical endpoint? Analysis of three phase 3 trials of tofacitinib:. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2012-eular.2117] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
90
|
Genovese M, van Vollenhoven R, Wilkinson B, Wang L, Zwillich S, Gruben D, Benda B, Jones T, Bradley J. OP0046 Tofacitinib, an Oral Janus Kinase Inhibitor, in a Rheumatoid Arthritis Open-Label Extension Study Following Adalimumab Therapy in a Phase 3 Randomised Clinical Trial. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.251] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
91
|
Isaacs J, Nduaka C, Zuckerman A, Krishnaswami S, Riese R, Lan S, Hutmacher M, Boy M, Bradley J. AB0595 Changes in serum creatinine in patients with active rheumatoid arthritis treated with TOFACITINIB (CP-690,550). Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2012-eular.595] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
92
|
Huizinga TWJ, Fleischmann R, van Vollenhoven R, Gruben D, Wilkinson B, Koncz T, Bradley J, Zwillich SH, Benda B. THU0225 Tofacitinib Monotherapy is Effective in Methotrexate-NaÏVe Patients with Disease Duration Less Than 6 Months: a Post-HOC Analysis of Early Rheumatoid Arthritis Subjects in a Phase 3 Trial. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.753] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
93
|
McInnes IB, Kaplan I, Boy M, Riese R, Zuckerman A, Gruben D, Brosnan MJ, Zwillich S, Bradley J. FRI0137 Effects of tofacitinib on lipid biomarkers in patients with active rheumatoid arthritis. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.1264] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
94
|
Fogel R, Sridharan S, Li C, Bradley J, Riese R, Labadie R, Menon S, Gupta P, Krishnasawami S, Beebe J. AB0724 Safety, pharmacokinetics, and pharmacodynamics of a human anti-IL6 monoclonal antibody PF-04236921 in healthy subjects. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2012-eular.724] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
95
|
Yin F, Benedict S, Bradley J, Cai J, Wijesooriya K. WE-A-500-01: Quality Control of Lung SBRT: Minimizing Uncertainties From Simulation to Treatment. Med Phys 2013. [DOI: 10.1118/1.4815490] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
96
|
Zuniga A, Apte A, Bradley J, Thorstad W, Deasy J. SU-E-T-244: Interfractional Motion Simulation of Head and Neck and Lung Patients Correlated to Treatment Outcome. Med Phys 2013. [DOI: 10.1118/1.4814679] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
97
|
McInnes I, Kaplan I, Boy M, Riese R, Zuckerman A, Clark J, Kishore N, Brosnan M, Zwillich S, Bradley J. AB0160 Effects of TOFACITINIB (CP-690,550) on lipid biomarkers in rat adjuvant-induced arthritis (AIA) model and in patients with active rheumatoid arthritis. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2012-eular.160] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
98
|
Vieira MC, Wallenstein G, Bradley J, Gruben D, Koncz T, Zwillich SH, Jansen JP. SAT0115 Tofacitinib Versus Biologic Treatments in Patients with Active Rheumatoid Arthritis Who have had an Inadequate Response to Tumour Necrosis Factor Inhibitors - A Network Meta-Analysis. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.1841] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
99
|
Oh J, Bradley J, Deasy J. SU-D-137-01: Prediction of Multi-Categorical Radiation Pneumonitis Status in Lung Cancer Patients Using Machine Learning Approaches. Med Phys 2013. [DOI: 10.1118/1.4814004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
100
|
Charles-Schoeman C, Wicker P, Sechtem U, Gonzalez-Gay M, Wood S, Boy M, Geier J, Gruben D, Soma K, Riese R, Bradley J. THU0136 Cardiovascular safety findings in rheumatoid arthritis patients treated with tofacitinib (CP-690,550), a novel, oral jak inhibitor:. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2012-eular.2101] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|